Literature DB >> 8386948

Histologic types and hormone receptors in breast cancer in men: a population-based study in 282 United States men.

H Stalsberg1, D B Thomas, K A Rosenblatt, L M Jimenez, A McTiernan, A Stemhagen, W D Thompson, M G Curnen, W Satariano, D F Austin.   

Abstract

Histologic slides from 282 incident cases of breast cancer in men, that were identified in 10 population-based cancer registries in the United States, were reviewed by a single pathologist. Breast cancer more often presented in the noninvasive stage in men (10.8 percent of all cases) than would be expected among women. All noninvasive carcinomas were of the ductal type. Of invasive carcinomas, compared with women, men had smaller proportions of lobular and mucinous types and larger proportions of ductal and papillary types and Paget's disease. No case of tubular or medullary carcinoma was seen. The breast in men is composed only of ducts and normally contains no lobules, and the histologic types of breast carcinomas that predominate in men are likely of ductal origin. Estrogen and progesterone receptors were present in 86.7 percent and 76.3 percent of invasive carcinomas, respectively, which are higher proportions than would be expected among women. Also, unlike findings in women, receptor content was not associated with patient age at diagnosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8386948     DOI: 10.1007/bf00053155

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  48 in total

1.  Secretory breast carcinoma in a man.

Authors:  J A Roth; C Discafani; M O'Malley
Journal:  Am J Surg Pathol       Date:  1988-02       Impact factor: 6.394

Review 2.  Oestrogen receptors and breast cancer: current status.

Authors:  R A Hawkins; M M Roberts; A P Forrest
Journal:  Br J Surg       Date:  1980-03       Impact factor: 6.939

3.  The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4).

Authors:  E R Fisher; R M Gregorio; B Fisher; C Redmond; F Vellios; S C Sommers
Journal:  Cancer       Date:  1975-07       Impact factor: 6.860

4.  Estrogen and progesterone receptors in breast cancer patients. Epidemiologic characteristics and survival differences.

Authors:  A M Ruder; F Lubin; Y Wax; A Geier; E Alfundary; A Chetrit
Journal:  Cancer       Date:  1989-07-01       Impact factor: 6.860

5.  Tubulolobular invasive breast cancer: a variant of lobular invasive cancer.

Authors:  E R Fisher; R M Gregorio; C Redmond; B Fisher
Journal:  Hum Pathol       Date:  1977-11       Impact factor: 3.466

6.  Invasive lobular carcinoma of the breast: incidence and variants.

Authors:  V Martinez; J G Azzopardi
Journal:  Histopathology       Date:  1979-11       Impact factor: 5.087

7.  Noninvasive breast carcinoma: results of a national survey by the American College of Surgeons.

Authors:  D Rosner; R N Bedwani; J Vana; H W Baker; G P Murphy
Journal:  Ann Surg       Date:  1980-08       Impact factor: 12.969

8.  Pathologic findings from the National Surgical Adjuvant Breast Project (protocol no. 4). VI. Invasive papillary cancer.

Authors:  E R Fisher; A S Palekar; C Redmond; B Barton; B Fisher
Journal:  Am J Clin Pathol       Date:  1980-03       Impact factor: 2.493

9.  Estrogen receptors in male breast cancer.

Authors:  N Gupta; J L Cohen; C Rosenbaum; S Raam
Journal:  Cancer       Date:  1980-10-15       Impact factor: 6.860

Review 10.  Paget's disease of the male breast.

Authors:  F Serour; S Birkenfeld; E Amsterdam; O Treshchan; M Krispin
Journal:  Cancer       Date:  1988-08-01       Impact factor: 6.860

View more
  16 in total

1.  Postoperative radiotherapy in the treatment of male breast carcinoma: a single institute experience.

Authors:  Lale Atahan; Ferah Yildiz; Ugur Selek; Sait Sari; Murat Gurkaynak
Journal:  J Natl Med Assoc       Date:  2006-04       Impact factor: 1.798

2.  Endocrine therapy for male breast cancer: rates of toxicity and adherence.

Authors:  H Visram; F Kanji; S F Dent
Journal:  Curr Oncol       Date:  2010-10       Impact factor: 3.677

3.  Male breast cancer: presenting as synchronous, large, bilateral masses.

Authors:  Sunil Vitthalrao Jagtap; P G Chougule; Wasim Khatib; Dhirajkumar B Shukla; Swati Sunil Jagtap
Journal:  J Clin Diagn Res       Date:  2014-04-15

4.  Case-control study of occupational exposures and male breast cancer.

Authors:  P Cocco; L Figgs; M Dosemeci; R Hayes; M S Linet; A W Hsing
Journal:  Occup Environ Med       Date:  1998-09       Impact factor: 4.402

Review 5.  The Epidemiology of Male Breast Cancer.

Authors:  Raina M Ferzoco; Kathryn J Ruddy
Journal:  Curr Oncol Rep       Date:  2016-01       Impact factor: 5.075

Review 6.  Male breast cancer: an update in diagnosis, treatment and molecular profiling.

Authors:  Susan Onami; Melanie Ozaki; Joanne E Mortimer; Sumanta Kumar Pal
Journal:  Maturitas       Date:  2010-02-06       Impact factor: 4.342

Review 7.  Estrogen receptor content in malignant breast tumors in men--a review.

Authors:  H Olsson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-07       Impact factor: 2.673

Review 8.  HER2-positive male breast cancer: an update.

Authors:  Laura Ottini; Carlo Capalbo; Piera Rizzolo; Valentina Silvestri; Giuseppe Bronte; Sergio Rizzo; Antonio Russo
Journal:  Breast Cancer (Dove Med Press)       Date:  2010-10-04

9.  Male breast cancer according to tumor subtype and race: a population-based study.

Authors:  Mariana Chavez-Macgregor; Christina A Clarke; Daphne Lichtensztajn; Gabriel N Hortobagyi; Sharon H Giordano
Journal:  Cancer       Date:  2013-01-22       Impact factor: 6.860

10.  Clinicopathological study of male breast carcinoma: 24 years of experience.

Authors:  Parveen Shah; Irfan Robbani; Omar Shah
Journal:  Ann Saudi Med       Date:  2009 Jul-Aug       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.